India, April 2 -- Shares of Sunshine Biopharma, Inc. (SBFM) soared over 70% on Wednesday morning after the company announced positive results of mRNA therapy for cancer.
SBFM is currently trading at $3.5906, up $1.5006 or 71.4776%, on a huge volume of 36.5 million shares, above average volume of 71 thousand, on the Nasdaq. The stock opened its trading at $3.3000 after closing Tuesday at $2.0900. The stock has traded between $1.9000 and $248.0000 in the past 52-week period.
Sunshine Biopharma announced that it has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid Nanoparticle (K1.1-mRNA-LNP) product as a novel therapeutic agent for human hepatocellular carcinoma.
googletag.cmd.push(functi...